Completed Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 NCT02251457 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +12 more Locations The Ohio State University Wexner Medical Center — Columbus, Ohio, United States View Trial Details
Completed Lamotrigine as Treatment of Myotonia NCT01939561 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dystrophia Myotonica Type 1, Genetic Diseases, Inborn, +26 more Locations Copenhagen Neuromuscular Center, department of Neurology, Rigshospitalet — Copenhagen, Denmark View Trial Details
Completed Mexiletine and Non Dystrophic Myotonias NCT02336477 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +9 more Locations Groupe Hospitalier Pitié Salpetriere — Paris, France View Trial Details
Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders NCT00004802 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Genetic Diseases, Inborn, +19 more Locations Not specified View Trial Details
